Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 117

1.

Evaluation of electromagnetic and nuclear scattering models in GATE/Geant4 for proton therapy.

Resch AF, Elia A, Fuchs H, Carlino A, Palmans H, Stock M, Georg D, Grevillot L.

Med Phys. 2019 May;46(5):2444-2456. doi: 10.1002/mp.13472. Epub 2019 Apr 15.

PMID:
30870583
2.

Speaking on Data's Behalf: What Researchers Say and How Audiences Choose.

Chandler JJ, Martinez I, Finucane MM, Terziev JG, Resch AM.

Eval Rev. 2019 Mar 13:193841X19834968. doi: 10.1177/0193841X19834968. [Epub ahead of print]

PMID:
30866674
3.

Correction to: DNA copy number evolution in Drosophila cell lines.

Lee H, McManus CJ, Cho DY, Eaton M, Renda F, Somma MP, Cherbas L, May G, Powell S, Zhang D, Zhan L, Resch A, Andrews J, Celniker SE, Cherbas P, Przytycka TM, Gatti M, Oliver B, Graveley B, MacAlpine D.

Genome Biol. 2019 Mar 11;20(1):53. doi: 10.1186/s13059-019-1668-5.

4.

Indications for a moonlighting function of translation factor aIF5A in the crenarchaeum Sulfolobus solfataricus.

Bassani F, Zink IA, Pribasnig T, Wolfinger MT, Romagnoli A, Resch A, Schleper C, Bläsi U, La Teana A.

RNA Biol. 2019 May;16(5):675-685. doi: 10.1080/15476286.2019.1582953. Epub 2019 Mar 5.

PMID:
30777488
5.

Co-Culturing Human Adipose Derived Stem Cells and Schwann Cells on Spider Silk-A New Approach as Prerequisite for Enhanced Nerve Regeneration.

Resch A, Wolf S, Mann A, Weiss T, Stetco AL, Radtke C.

Int J Mol Sci. 2018 Dec 24;20(1). pii: E71. doi: 10.3390/ijms20010071.

6.

Harnessing Metabolic Regulation to Increase Hfq-Dependent Antibiotic Susceptibility in Pseudomonas aeruginosa.

Pusic P, Sonnleitner E, Krennmayr B, Heitzinger DA, Wolfinger MT, Resch A, Bläsi U.

Front Microbiol. 2018 Nov 9;9:2709. doi: 10.3389/fmicb.2018.02709. eCollection 2018.

7.

RD or Not RD: Using Experimental Studies to Assess the Performance of the Regression Discontinuity Approach.

Gleason P, Resch A, Berk J.

Eval Rev. 2018 Feb;42(1):3-33. doi: 10.1177/0193841X18787267. Epub 2018 Aug 20.

PMID:
30126296
8.

Quality-of-life results for accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation in early breast cancer after breast-conserving surgery (GEC-ESTRO): 5-year results of a randomised, phase 3 trial.

Schäfer R, Strnad V, Polgár C, Uter W, Hildebrandt G, Ott OJ, Kauer-Dorner D, Knauerhase H, Major T, Lyczek J, Guinot JL, Dunst J, Miguelez CG, Slampa P, Allgäuer M, Lössl K, Kovács G, Fischedick AR, Fietkau R, Resch A, Kulik A, Arribas L, Niehoff P, Guedea F, Schlamann A, Gall C, Polat B; Groupe Européen de Curiethérapie of European Society for Radiotherapy and Oncology (GEC-ESTRO).

Lancet Oncol. 2018 Jun;19(6):834-844. doi: 10.1016/S1470-2045(18)30195-5. Epub 2018 Apr 22.

PMID:
29695348
9.

Monte Carlo proton dose calculations using a radiotherapy specific dual-energy CT scanner for tissue segmentation and range assessment.

Almeida IP, Schyns LEJR, Vaniqui A, van der Heyden B, Dedes G, Resch AF, Kamp F, Zindler JD, Parodi K, Landry G, Verhaegen F.

Phys Med Biol. 2018 May 29;63(11):115008. doi: 10.1088/1361-6560/aabb60.

PMID:
29616662
10.

Interplay between the catabolite repression control protein Crc, Hfq and RNA in Hfq-dependent translational regulation in Pseudomonas aeruginosa.

Sonnleitner E, Wulf A, Campagne S, Pei XY, Wolfinger MT, Forlani G, Prindl K, Abdou L, Resch A, Allain FH, Luisi BF, Urlaub H, Bläsi U.

Nucleic Acids Res. 2018 Feb 16;46(3):1470-1485. doi: 10.1093/nar/gkx1245.

11.

A Monte-Carlo study to assess the effect of 1.5 T magnetic fields on the overall robustness of pencil-beam scanning proton radiotherapy plans for prostate cancer.

Kurz C, Landry G, Resch AF, Dedes G, Kamp F, Ganswindt U, Belka C, Raaymakers BW, Parodi K.

Phys Med Biol. 2017 Oct 19;62(21):8470-8482. doi: 10.1088/1361-6560/aa8de9.

PMID:
29047455
12.

Quality of survival and cognitive performance in children treated for medulloblastoma in the PNET 4 randomized controlled trial.

Câmara-Costa H, Bull KS, Kennedy C, Wiener A, Calaminus G, Resch A, Kieffer V, Lalande C, Poggi G, von Hoff K, Grill J, Doz F, Rutkowski S, Massimino M, Kortmann RD, Lannering B, Dellatolas G, Chevignard M; Quality of Survival working group of the Brain Tumour Group of SIOP-Europe.

Neurooncol Pract. 2017 Sep;4(3):161-170. doi: 10.1093/nop/npw028. Epub 2017 Feb 10.

13.

Benchmarking GATE/Geant4 for 16O ion beam therapy.

Resch AF, Fuchs H, Georg D.

Phys Med Biol. 2017 Sep 5;62(18):N474-N484. doi: 10.1088/1361-6560/aa807e.

PMID:
28718770
14.

Quantification of the uncertainties of a biological model and their impact on variable RBE proton treatment plan optimization.

Resch AF, Landry G, Kamp F, Cabal G, Belka C, Wilkens JJ, Parodi K, Dedes G.

Phys Med. 2017 Apr;36:91-102. doi: 10.1016/j.ejmp.2017.03.013. Epub 2017 Mar 30.

PMID:
28410691
15.

Late side-effects and cosmetic results of accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: 5-year results of a randomised, controlled, phase 3 trial.

Polgár C, Ott OJ, Hildebrandt G, Kauer-Dorner D, Knauerhase H, Major T, Lyczek J, Guinot JL, Dunst J, Miguelez CG, Slampa P, Allgäuer M, Lössl K, Polat B, Kovács G, Fischedick AR, Fietkau R, Resch A, Kulik A, Arribas L, Niehoff P, Guedea F, Schlamann A, Pötter R, Gall C, Uter W, Strnad V; Groupe Européen de Curiethérapie of European Society for Radiotherapy and Oncology (GEC-ESTRO).

Lancet Oncol. 2017 Feb;18(2):259-268. doi: 10.1016/S1470-2045(17)30011-6. Epub 2017 Jan 14.

PMID:
28094198
16.

Pseudomembranes Carpet the Right Colon as a Result of Collagenous Colitis.

Resch A, Eherer A, Langner C.

Clin Gastroenterol Hepatol. 2017 May;15(5):e95-e96. doi: 10.1016/j.cgh.2016.10.002. Epub 2016 Oct 8. No abstract available.

PMID:
27725290
17.

GEC-ESTRO multicenter phase 3-trial: Accelerated partial breast irradiation with interstitial multicatheter brachytherapy versus external beam whole breast irradiation: Early toxicity and patient compliance.

Ott OJ, Strnad V, Hildebrandt G, Kauer-Dorner D, Knauerhase H, Major T, Łyczek J, Guinot JL, Dunst J, Miguelez CG, Slampa P, Allgäuer M, Lössl K, Polat B, Kovács G, Fischedick AR, Wendt TG, Fietkau R, Kortmann RD, Resch A, Kulik A, Arribas L, Niehoff P, Guedea F, Schlamann A, Pötter R, Gall C, Malzer M, Uter W, Polgár C; Groupe Européen de Curiethérapie of European Society for Radiotherapy and Oncology (GEC-ESTRO).

Radiother Oncol. 2016 Jul;120(1):119-23. doi: 10.1016/j.radonc.2016.06.019. Epub 2016 Jul 12.

PMID:
27422584
18.

Impact of heterogeneity-corrected dose calculation using a grid-based Boltzmann solver on breast and cervix cancer brachytherapy.

Hofbauer J, Kirisits C, Resch A, Xu Y, Sturdza A, Pötter R, Nesvacil N.

J Contemp Brachytherapy. 2016 Apr;8(2):143-9. doi: 10.5114/jcb.2016.59352. Epub 2016 Apr 19.

19.

Inclusion of cytological features in tumor grading improves prognostic stratification of patients with colorectal cancer.

Resch A, Harbaum L, Pollheimer MJ, Kornprat P, Lindtner RA, Langner C.

Int J Colorectal Dis. 2016 Mar;31(3):535-41. doi: 10.1007/s00384-015-2495-0. Epub 2016 Jan 26.

PMID:
26809770
20.

5-year results of accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: a randomised, phase 3, non-inferiority trial.

Strnad V, Ott OJ, Hildebrandt G, Kauer-Dorner D, Knauerhase H, Major T, Lyczek J, Guinot JL, Dunst J, Gutierrez Miguelez C, Slampa P, Allgäuer M, Lössl K, Polat B, Kovács G, Fischedick AR, Wendt TG, Fietkau R, Hindemith M, Resch A, Kulik A, Arribas L, Niehoff P, Guedea F, Schlamann A, Pötter R, Gall C, Malzer M, Uter W, Polgár C; Groupe Européen de Curiethérapie of European Society for Radiotherapy and Oncology (GEC-ESTRO).

Lancet. 2016 Jan 16;387(10015):229-38. doi: 10.1016/S0140-6736(15)00471-7. Epub 2015 Oct 19.

PMID:
26494415
21.

Strategies to improve the quality of survival for childhood brain tumour survivors.

Tallen G, Resch A, Calaminus G, Wiener A, Leiss U, Pletschko T, Friedrich C, Langer T, Grabow D, Driever PH, Kortmann RD, Timmermann B, Pietsch T, Warmuth-Metz M, Bison B, Thomale UW, Krauss J, Mynarek M, von Hoff K, Ottensmeier H, Frühwald M, Kramm CM, Temming P, Müller HL, Witt O, Kordes U, Fleischhack G, Gnekow A, Rutkowski S; German Paediatric Brain Tumour Consortium (HIT-Network).

Eur J Paediatr Neurol. 2015 Nov;19(6):619-39. doi: 10.1016/j.ejpn.2015.07.011. Epub 2015 Jul 26. Review.

PMID:
26278499
22.

Interobserver variations of target volume delineation in multicatheter partial breast brachytherapy after open cavity surgery.

Major T, Gutiérrez C, Guix B, Mózsa E, Hannoun-Levi JM, Lössl K, Niehoff P, Resch A, van Limbergen E, Polgár C.

Brachytherapy. 2015 Nov-Dec;14(6):925-32. doi: 10.1016/j.brachy.2015.06.008. Epub 2015 Jul 21.

PMID:
26209477
23.

Comparing cone-beam CT intensity correction methods for dose recalculation in adaptive intensity-modulated photon and proton therapy for head and neck cancer.

Kurz C, Dedes G, Resch A, Reiner M, Ganswindt U, Nijhuis R, Thieke C, Belka C, Parodi K, Landry G.

Acta Oncol. 2015;54(9):1651-7. doi: 10.3109/0284186X.2015.1061206. Epub 2015 Jul 22.

PMID:
26198654
24.

Neuropsychological Outcome of Children Treated for Standard Risk Medulloblastoma in the PNET4 European Randomized Controlled Trial of Hyperfractionated Versus Standard Radiation Therapy and Maintenance Chemotherapy.

Câmara-Costa H, Resch A, Kieffer V, Lalande C, Poggi G, Kennedy C, Bull K, Calaminus G, Grill J, Doz F, Rutkowski S, Massimino M, Kortmann RD, Lannering B, Dellatolas G, Chevignard M; Quality of Survival Working Group of the Brain Tumour Group of SIOP-Europe.

Int J Radiat Oncol Biol Phys. 2015 Aug 1;92(5):978-985. doi: 10.1016/j.ijrobp.2015.04.023. Epub 2015 Apr 17.

PMID:
26194675
25.

Recommendations from GEC ESTRO Breast Cancer Working Group (I): Target definition and target delineation for accelerated or boost Partial Breast Irradiation using multicatheter interstitial brachytherapy after breast conserving closed cavity surgery.

Strnad V, Hannoun-Levi JM, Guinot JL, Lössl K, Kauer-Dorner D, Resch A, Kovács G, Major T, Van Limbergen E; Working Group Breast Cancer of GEC-ESTRO.

Radiother Oncol. 2015 Jun;115(3):342-8. doi: 10.1016/j.radonc.2015.06.010. Epub 2015 Jun 20.

PMID:
26104975
26.

Grading lymph node metastasis: a feasible approach for prognostication of patients with stage III colorectal cancer.

Resch A, Harbaum L, Pollheimer MJ, Kornprat P, Lindtner RA, Langner C.

J Clin Pathol. 2015 Sep;68(9):742-5. doi: 10.1136/jclinpath-2014-202772. Epub 2015 Jun 16.

PMID:
26082514
27.

Pathological evaluation of colorectal cancer specimens: advanced and early lesions.

Resch A, Schneider NI, Langner C.

Cesk Patol. 2015;51(1):12-22.

PMID:
25671357
28.

Risk assessment in early colorectal cancer: histological and molecular markers.

Resch A, Langner C.

Dig Dis. 2015;33(1):77-85. doi: 10.1159/000366036. Epub 2014 Dec 17. Review.

PMID:
25531500
29.

DNA copy number evolution in Drosophila cell lines.

Lee H, McManus CJ, Cho DY, Eaton M, Renda F, Somma MP, Cherbas L, May G, Powell S, Zhang D, Zhan L, Resch A, Andrews J, Celniker SE, Cherbas P, Przytycka TM, Gatti M, Oliver B, Graveley B, MacAlpine D.

Genome Biol. 2014 Aug 28;15(8):R70. doi: 10.1186/gb-2014-15-8-r70. Erratum in: Genome Biol. 2019 Mar 11;20(1):53.

30.

Treatment of children with central nervous system primitive neuroectodermal tumors/pinealoblastomas in the prospective multicentric trial HIT 2000 using hyperfractionated radiation therapy followed by maintenance chemotherapy.

Gerber NU, von Hoff K, Resch A, Ottensmeier H, Kwiecien R, Faldum A, Matuschek C, Hornung D, Bremer M, Benesch M, Pietsch T, Warmuth-Metz M, Kuehl J, Rutkowski S, Kortmann RD.

Int J Radiat Oncol Biol Phys. 2014 Jul 15;89(4):863-71. doi: 10.1016/j.ijrobp.2014.04.017.

PMID:
24969797
31.

Is oncoplastic surgery a contraindication for accelerated partial breast radiation using the interstitial multicatheter brachytherapy method?

Roth AM, Kauer-Dorner D, Resch A, Schmid A, Thill M, Niehoff P, Melchert C, Berger D, Kovács G; Groupe Europeen de Curietherapie-European Society for Therapeutic Radiology and Oncology (GEC-ESTRO) Breast Working Group.

Brachytherapy. 2014 Jul-Aug;13(4):394-9. doi: 10.1016/j.brachy.2013.09.003.

PMID:
24946973
32.

Neonatal total bilirubin measurements: Still room for harmonization.

Greene DN, Liang J, Holmes DT, Resch A, Lorey TS.

Clin Biochem. 2014 Aug;47(12):1112-5. doi: 10.1016/j.clinbiochem.2014.04.001. Epub 2014 Apr 13.

PMID:
24731789
33.

Duplex formation between the sRNA DsrA and rpoS mRNA is not sufficient for efficient RpoS synthesis at low temperature.

Hämmerle H, Večerek B, Resch A, Bläsi U.

RNA Biol. 2013 Dec;10(12):1834-41. doi: 10.4161/rna.27100. Epub 2013 Nov 13.

34.

Recent developments and current concepts in medulloblastoma.

Gerber NU, Mynarek M, von Hoff K, Friedrich C, Resch A, Rutkowski S.

Cancer Treat Rev. 2014 Apr;40(3):356-65. doi: 10.1016/j.ctrv.2013.11.010. Epub 2013 Dec 6. Review.

PMID:
24389035
35.

Lymph node staging in colorectal cancer: old controversies and recent advances.

Resch A, Langner C.

World J Gastroenterol. 2013 Dec 14;19(46):8515-26. doi: 10.3748/wjg.v19.i46.8515. Review.

36.

Identification of neoblast- and regeneration-specific miRNAs in the planarian Schmidtea mediterranea.

Sasidharan V, Lu YC, Bansal D, Dasari P, Poduval D, Seshasayee A, Resch AM, Graveley BR, Palakodeti D.

RNA. 2013 Oct;19(10):1394-404. doi: 10.1261/rna.038653.113. Epub 2013 Aug 23.

37.

Accelerated partial breast irradiation with interstitial brachytherapy as second conservative treatment for ipsilateral breast tumour recurrence: multicentric study of the GEC-ESTRO Breast Cancer Working Group.

Hannoun-Levi JM, Resch A, Gal J, Kauer-Dorner D, Strnad V, Niehoff P, Loessl K, Kovács G, Van Limbergen E, Polgár C; GEC-ESTRO Breast Cancer Working Group.

Radiother Oncol. 2013 Aug;108(2):226-31. doi: 10.1016/j.radonc.2013.03.026. Epub 2013 May 3.

PMID:
23647758
38.
39.

German, Austrian and Swiss consensus conference on the diagnosis and local treatment of the axilla in breast cancer.

AGO; DGS; SGS; ÖGS; Panelists; Executive Board Members, Hoffmann J, Souchon R, Lebeau A, Öhlschlegel C, Gruber G, Rageth C, Weber W, Harbeck N, Janni W, Kreipe H, Fitzal F, Resch A, Bago-Horvath Z, Peintinger F.

Eur J Cancer. 2013 Jul;49(10):2277-83. doi: 10.1016/j.ejca.2013.01.034. Epub 2013 Mar 13.

PMID:
23490652
40.

XACT, a long noncoding transcript coating the active X chromosome in human pluripotent cells.

Vallot C, Huret C, Lesecque Y, Resch A, Oudrhiri N, Bennaceur-Griscelli A, Duret L, Rougeulle C.

Nat Genet. 2013 Mar;45(3):239-41. doi: 10.1038/ng.2530. Epub 2013 Jan 20.

PMID:
23334669
41.

Transcriptome analysis reveals strain-specific and conserved stemness genes in Schmidtea mediterranea.

Resch AM, Palakodeti D, Lu YC, Horowitz M, Graveley BR.

PLoS One. 2012;7(4):e34447. doi: 10.1371/journal.pone.0034447. Epub 2012 Apr 4.

42.

Small N designs for rehabilitation research.

Barnett SD, Heinemann AW, Libin A, Houts AC, Gassaway J, Sen-Gupta S, Resch A, Brossart DF.

J Rehabil Res Dev. 2012;49(1):175-86.

43.

Small RNA pathways in Schmidtea mediterranea.

Resch AM, Palakodeti D.

Int J Dev Biol. 2012;56(1-3):67-74. doi: 10.1387/ijdb.113436ar. Review.

44.

Essential features and rational design of CRISPR RNAs that function with the Cas RAMP module complex to cleave RNAs.

Hale CR, Majumdar S, Elmore J, Pfister N, Compton M, Olson S, Resch AM, Glover CV 3rd, Graveley BR, Terns RM, Terns MP.

Mol Cell. 2012 Feb 10;45(3):292-302. doi: 10.1016/j.molcel.2011.10.023. Epub 2012 Jan 5.

45.
46.

Disruption and complementation of the selenocysteine biosynthesis pathway reveals a hierarchy of selenoprotein gene expression in the archaeon Methanococcus maripaludis.

Stock T, Selzer M, Connery S, Seyhan D, Resch A, Rother M.

Mol Microbiol. 2011 Nov;82(3):734-47. doi: 10.1111/j.1365-2958.2011.07850.x. Epub 2011 Oct 12.

47.

Partial breast irradiation for locally recurrent breast cancer within a second breast conserving treatment: alternative to mastectomy? Results from a prospective trial.

Kauer-Dorner D, Pötter R, Resch A, Handl-Zeller L, Kirchheiner K, Meyer-Schell K, Dörr W.

Radiother Oncol. 2012 Jan;102(1):96-101. doi: 10.1016/j.radonc.2011.07.020. Epub 2011 Sep 8.

PMID:
21907439
48.

Loss of DNA mismatch repair imparts a selective advantage in planarian adult stem cells.

Hollenbach JP, Resch AM, Palakodeti D, Graveley BR, Heinen CD.

PLoS One. 2011;6(7):e21808. doi: 10.1371/journal.pone.0021808. Epub 2011 Jul 1.

49.

Requirement of the CsdA DEAD-box helicase for low temperature riboregulation of rpoS mRNA.

Resch A, Većerek B, Palavra K, Bläsi U.

RNA Biol. 2010 Nov-Dec;7(6):796-802. Epub 2010 Nov 1.

50.

Accelerated partial breast irradiation with interstitial implants: risk factors associated with increased local recurrence.

Ott OJ, Hildebrandt G, Pötter R, Hammer J, Hindemith M, Resch A, Spiegl K, Lotter M, Uter W, Kortmann RD, Schrauder M, Beckmann MW, Fietkau R, Strnad V.

Int J Radiat Oncol Biol Phys. 2011 Aug 1;80(5):1458-63. doi: 10.1016/j.ijrobp.2010.04.032. Epub 2010 Aug 2.

PMID:
20675064

Supplemental Content

Support Center